Grab This Deal Even Lower Than Director Doordan Did

Posted on May 23, 2012 at 09:57 AM EDT

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 8, DexCom Inc's Director, Martin Doordan, invested $20,709.00 into 2,000 shares of DXCM, for a cost per share of $10.35.

Related Stocks:

DexCom, Inc. SPDR S&P Health Care Equipment ETF

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates